ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

This study is currently recruiting participants.
Study NCT00660101.   Last updated on December 3, 2008.   Information provided by AVAX Technologies

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Adenocarcinoma of the Ovary
2 Additional conditions recognized in this trial
Adenocarcinoma
Ovarian Neoplasms
3 More general conditions related to this trial
Adnexal Diseases
Carcinoma
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Ovarian Diseases
Urogenital Neoplasms
4 Sponsors listed in this trial
AVAX Technologies




Links to all studies - primarily for crawlers